舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300204 舒泰神

已收盘 12-05 15:00:00

{"stockData":{"symbol":"300204","market":"SZ","secType":"STK","nameCN":"舒泰神","latestPrice":27.56,"timestamp":1764918210000,"preClose":27.2,"halted":0,"volume":20650563,"delay":0,"changeRate":0.0132,"floatShares":454000000,"shares":478000000,"eps":-0.3478,"marketStatus":"已收盘","change":0.36,"latestTime":"12-05 15:00:00","open":27.25,"high":27.67,"low":26.47,"amount":559000000,"amplitude":0.0441,"askPrice":27.56,"askSize":490,"bidPrice":27.55,"bidSize":296,"shortable":0,"etf":0,"ttmEps":-0.3478,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":27.2,"symbolType":"stock","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":29.92,"lowLimit":24.48,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":477772555,"isCdr":false,"pbRate":14.93,"roa":"--","roe":"--","epsLYR":-0.3,"committee":-0.179743,"marketValue":13167000000,"turnoverRate":0.0455,"status":0,"floatMarketCap":12503000000},"requestUrl":"/m/hq/s/300204/tweets","defaultTab":"tweets","newsList":[{"id":"2589502658","title":"舒泰神：正按CDE要求补充STSP-0601材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2589502658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589502658?lang=zh_cn&edition=full","pubTime":"2025-12-05 11:48","pubTimestamp":1764906494,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神12月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，STSP0601新药目前说是需要补充材料，请问CDE具体要求公司补充哪方面的材料，公司估计补充材料大概需要多久完成，投资者有权知道，请正面回复，谢谢舒泰神回复：您好！公司近期收到国家药品监督管理局药品审评中心就STSP-0601项目发出的发补通知。公司高度重视，正在按照通知要求组织相关部门落实并尽快补充提交相关材料。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500014130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300204","BK0239","BK0028"],"gpt_icon":0},{"id":"2589285022","title":"舒泰神：香塘集团计划减持不超过1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2589285022","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589285022?lang=zh_cn&edition=full","pubTime":"2025-12-05 11:48","pubTimestamp":1764906491,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神12月04日在投资者关系平台上答复投资者关心的问题。根据公司2025年11月05日披露的《关于持股5%以上股东减持股份的预披露公告》，“香塘集团计划自本公告披露之日起15个交易日后的3个月内，即 2025年11月27日至2026年02月26日期间，以大宗交易方式减持股份不超过477.77万股，占公司总股本的1%”。公司将根据相关法规要求，及时履行信息披露义务，敬请关注后续进展公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500014121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0046","300204"],"gpt_icon":0},{"id":"2588011519","title":"舒泰神（300204）披露拟向银行申请贷款并提供抵押反担保的进展公告，12月03日股价下跌3.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588011519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588011519?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:02","pubTimestamp":1764752568,"startTime":"0","endTime":"0","summary":"截至2025年12月3日收盘，舒泰神报收于27.59元，较前一交易日下跌3.26%，最新总市值为131.82亿元。公司近日发布公告称，拟向多家银行申请不超过20,000万元人民币贷款，用于公司及下属子公司日常经营周转。公司委托北京亦庄国际融资担保有限公司为上述贷款提供保证担保，并以自有房产及土地使用权提供反担保，预计反担保额度不超过30,000万元。被担保方亦庄担保与公司无关联关系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300025587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","161121","300204","BK0046","BK0239"],"gpt_icon":0},{"id":"2588080520","title":"12月2日舒泰神跌5.31%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588080520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588080520?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:33","pubTimestamp":1764660825,"startTime":"0","endTime":"0","summary":"证券之星消息，12月2日舒泰神跌5.31%创60日新低，收盘报28.52元，换手率6.99%，成交量31.71万手，成交额9.11亿元。重仓舒泰神的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为38.02亿元，最新净值4.201，较上一交易日下跌0.85%，近一年上涨27.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200017330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300204","BK0239"],"gpt_icon":0},{"id":"2588702291","title":"舒泰神：BDB-001注射液首例入组已完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2588702291","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588702291?lang=zh_cn&edition=full","pubTime":"2025-12-02 09:02","pubTimestamp":1764637325,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司的BDB-001注射液的研发进度如何？BDB-001注射液在抗中性粒细胞胞质抗体相关性血管炎方向登记号为CTR20253611的临床试验首例已入组，并已在CDE平台公示。有关研发项目进展，敬请关注后续定期报告及项目进展公告。感谢您对公司的关注，谢谢！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200004552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0046","BK0239","BK0028"],"gpt_icon":0},{"id":"2586929144","title":"舒泰神：与奥克股份暂无研发方向合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2586929144","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586929144?lang=zh_cn&edition=full","pubTime":"2025-11-27 08:39","pubTimestamp":1764203951,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神(300204)11月26日在投资者关系平台上答复投资者关心的问题。投资者提问：奥克股份聚乙二醇取得世界级认证，同时也是公司供货商，请问公司目前与奥克股份有合作聚乙二醇药物深入开发吗舒泰神回复：您好！辽宁奥克药业股份有限公司为公司产品舒泰清原料供应商，公司与辽宁奥克暂无研发方向合作。感谢您对公司的关注，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700004237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300082","BK0070","BK0229","BK0028","BK0155","300204","BK0046","BK0201"],"gpt_icon":0},{"id":"2584164350","title":"11月17日舒泰神跌7.61%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584164350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584164350?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:34","pubTimestamp":1763368451,"startTime":"0","endTime":"0","summary":"证券之星消息，11月17日舒泰神跌7.61%，收盘报36.31元，换手率12.35%，成交量56.02万手，成交额20.67亿元。重仓舒泰神的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为38.02亿元，最新净值4.273，较上一交易日上涨0.42%，近一年上涨31.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700020919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0046","BK0239"],"gpt_icon":0},{"id":"2582882567","title":"11月10日舒泰神涨7.98%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582882567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582882567?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:34","pubTimestamp":1762763681,"startTime":"0","endTime":"0","summary":"证券之星消息，11月10日舒泰神涨7.98%，收盘报36.69元，换手率15.51%，成交量70.36万手，成交额25.72亿元。重仓舒泰神的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为38.02亿元，最新净值4.004，较上一交易日下跌1.55%，近一年上涨19.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300204","BK0046"],"gpt_icon":0},{"id":"2581409964","title":"舒泰神：公司不存在逾期担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2581409964","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581409964?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:09","pubTimestamp":1762434540,"startTime":"0","endTime":"0","summary":"证券日报网讯11月6日晚间，舒泰神发布公告称，公司不存在逾期担保、涉及诉讼的担保及因担保被判决败诉而应承担损失的情形。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-06/doc-infwnnht5512346.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-06/doc-infwnnht5512346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300204","BK0046","BK0028","BK0239"],"gpt_icon":0},{"id":"2581054982","title":"11月6日舒泰神跌6.62%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2581054982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581054982?lang=zh_cn&edition=full","pubTime":"2025-11-06 16:35","pubTimestamp":1762418126,"startTime":"0","endTime":"0","summary":"证券之星消息，11月6日舒泰神跌6.62%，收盘报34.72元，换手率11.92%，成交量54.08万手，成交额18.68亿元。重仓舒泰神的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为38.02亿元，最新净值4.067，较上一交易日下跌0.73%，近一年上涨22.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600025212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","300204","BK0239"],"gpt_icon":0},{"id":"2581972809","title":"舒泰神最新公告：股东香塘集团计划减持不超1%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2581972809","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581972809?lang=zh_cn&edition=full","pubTime":"2025-11-05 18:41","pubTimestamp":1762339260,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，持股5%以上股东香塘集团有限公司因自身资金需求，计划自公告披露之日起15个交易日后的3个月内，通过大宗交易方式减持不超过477.77万股，占公司总股本的1%。减持期间为2025年11月27日至2026年2月26日。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500034179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0046","BK0239"],"gpt_icon":0},{"id":"2579545384","title":"10月31日舒泰神（300204）龙虎榜数据：机构净买入1.98亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579545384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579545384?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:46","pubTimestamp":1761904016,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年10月31日公布的交易公开信息显示，舒泰神因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年10月31日收盘，舒泰神报收于38.3元，上涨19.99%，涨停，换手率15.01%，成交量68.09万手，成交额24.27亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入1.98亿元。上海超短帮等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100037716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300204","BK0239"],"gpt_icon":0},{"id":"2579194896","title":"10月30日舒泰神跌5.73%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579194896","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579194896?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:18","pubTimestamp":1761812337,"startTime":"0","endTime":"0","summary":"证券之星消息，10月30日舒泰神跌5.73%，收盘报31.92元，换手率6.0%，成交量27.23万手，成交额8.82亿元。重仓舒泰神的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为38.02亿元，最新净值4.072，较上一交易日下跌0.17%，近一年上涨22.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000029490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0046","BK0239"],"gpt_icon":0},{"id":"2579187315","title":"股市必读：舒泰神（300204）10月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2579187315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579187315?lang=zh_cn&edition=full","pubTime":"2025-10-30 02:52","pubTimestamp":1761763921,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，舒泰神报收于33.86元，上涨0.06%，换手率5.4%，成交量24.51万手，成交额8.2亿元。董秘最新回复投资者： 贵司是否考虑通过BD交易模式获取研发资金？公司对于临床前和临床阶段项目的海外权益及部分项目的国内权益的合作及多种合作模式均持开放态度。公司重视BD工作的开展，并有相应人员进行推动。当日关注点来自交易信息汇总：10月29日主力与游资资金均呈净流出态势，散户资金净流入7876.66万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000002885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0046","BK0239"],"gpt_icon":0},{"id":"2579924603","title":"舒泰神：对BD合作模式持开放态度","url":"https://stock-news.laohu8.com/highlight/detail?id=2579924603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579924603?lang=zh_cn&edition=full","pubTime":"2025-10-29 16:03","pubTimestamp":1761724990,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神(300204)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司是否考虑通过BD交易模式获取研发资金？舒泰神回复：您好！公司对于临床前和临床阶段项目的海外权益及部分项目的国内权益的合作及多种合作模式均持开放态度。公司重视BD工作的开展，并有相应人员进行推动。如您希望对公司进行更多了解，欢迎您致电公司投资者热线（010-67875255），谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900030877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300204","BK0028","BK0046"],"gpt_icon":0},{"id":"2578939175","title":"舒泰神(300204)9月30日股东户数4.65万户，较上期增加46.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939175","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939175?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:38","pubTimestamp":1761644327,"startTime":"0","endTime":"0","summary":"证券之星消息，近日舒泰神披露，截至2025年9月30日公司股东户数为4.65万户，较6月30日增加1.49万户，增幅为46.97%。在化学制药行业个股中，舒泰神股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年6月30日至2025年9月30日，舒泰神区间跌幅为6.09%，在此期间股东户数增加1.49万户，增幅为46.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800032128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","300204","BK0239"],"gpt_icon":0},{"id":"2578104616","title":"舒泰神（300204）披露向特定对象发行股票募集说明书，10月27日股价上涨0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578104616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578104616?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:17","pubTimestamp":1761556675,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，舒泰神报收于34.13元，较前一交易日上涨0.47%，最新总市值为163.06亿元。同日，舒泰神发布公告，披露《2025年度向特定对象发行股票募集说明书（申报稿）》。根据公告，公司拟向特定对象发行股票，募集资金总额不超过125,300.00万元，用于创新药物研发项目及补充流动资金。发行股票数量不超过发行前总股本的30%，即143,331,766股。本次发行已获董事会及股东会审议通过，尚需深交所审核及证监会注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700023751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0046","300204"],"gpt_icon":0},{"id":"2578357536","title":"舒泰神最新公告：拟定增募集资金总额不超12.53亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578357536","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578357536?lang=zh_cn&edition=full","pubTime":"2025-10-26 16:19","pubTimestamp":1761466765,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，公司拟向特定对象发行股票，募集资金总额不超过12.53亿元，用于创新药物研发项目和补充流动资金。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600006213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0028","BK0046","BK0239"],"gpt_icon":0},{"id":"2577750193","title":"10月23日舒泰神跌7.52%，长城医药产业精选混合发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2577750193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577750193?lang=zh_cn&edition=full","pubTime":"2025-10-23 16:05","pubTimestamp":1761206759,"startTime":"0","endTime":"0","summary":"证券之星消息，10月23日舒泰神跌7.52%，收盘报35.53元，换手率9.49%，成交量43.05万手，成交额15.32亿元。重仓舒泰神的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城医药产业精选混合发起式A。长城医药产业精选混合发起式A目前规模为3.8亿元，最新净值1.7983，较上一交易日下跌0.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300023572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300204","BK0046"],"gpt_icon":0},{"id":"2575401051","title":"舒泰神：公司将按照信息披露的要求在定期报告中披露相应时间点的股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2575401051","media":"证券日报 ","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575401051?lang=zh_cn&edition=full","pubTime":"2025-10-13 20:39","pubTimestamp":1760359140,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网讯舒泰神10月13日在互动平台回答投资者提问时表示，公司将按照信息披露的要求在定期报告中披露相应时间点的股东人数。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-13/doc-inftucqh5089642.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-13/doc-inftucqh5089642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300204","BK0239","BK0046","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1764953742120,"stockEarnings":[{"period":"1week","weight":-0.0904},{"period":"1month","weight":-0.2587},{"period":"3month","weight":-0.3203},{"period":"6month","weight":-0.0536},{"period":"1year","weight":2.3205},{"period":"ytd","weight":2.7193}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"舒泰神(北京)生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"46538人(较上一季度增加46.97%)","perCapita":"9748股","listingDate":"2011-04-15","address":"北京市大兴区北京经济技术开发区经海二路36号","registeredCapital":"47777万元","survey":"　　舒泰神(北京)生物制药股份有限公司的主营业务是生物药物的研发、生产和营销。公司的主要产品是创新生物药物苏肽生（注射用鼠神经生长因子）、特色品种舒泰清（复方聚乙二醇电解质散（IV））。","listedPrice":52.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"舒泰神,300204,舒泰神股票,舒泰神股票老虎,舒泰神股票老虎国际,舒泰神行情,舒泰神股票行情,舒泰神股价,舒泰神股市,舒泰神股票价格,舒泰神股票交易,舒泰神股票购买,舒泰神股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}